Eclipse Bioinnovations, Inc.

San Diego, CA

UEI
NKBUXMSL35L8
CAGE
7XLH4
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
5770 Oberlin Dr, San Diego, CA 92121, USA
Website
eclipsebio.com
Founded
2017
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Emoa: a multi-omic service for mechanism of action determination in drug screening R44GM154583 National Institute of General Medical Sciences (NIH) $4,007,848
Development of chimeric read amplification into a robust method for profiling targets of specific micrornas and… R44HG010603 National Human Genome Research Institute (NIH) $1,999,233
Unambiguous transcriptome-wide identification of microrna:mrna interactions through enhanced chimeric read amplification R43HG010603 National Human Genome Research Institute (NIH) $349,750
A robust kit, standards, and software for identifying RNA binding protein targets R44HG009875 National Human Genome Research Institute (NIH) $1,583,111

Similar vendors

Vendor Location Primary NAICS
Frameshift Labs, Inc. UEI WM2GPP9XLJ43 Cambridge, MA —
Claret Bioscience LLC UEI NBKDPRMF8Y27 Worcester, MA 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Epigenome Technologies, Inc. UEI LS7JQN77JKQ1 San Diego, CA 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Arima Genomics, Inc. UEI PKRJJSZRJ6M3 Carlsbad, CA 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Jumpcode Genomics Inc. UEI KJG3YNKKEKW6 — 541714 Research and Development in Biotechnology (except Nanobiotechnology)

See more similar vendors on GovTribe

About the company

Written by GovTribe AI ·

Eclipse Bioinnovations, Inc. is a for-profit organization registered with the U.S. federal government to receive contract and grant awards. The company specializes in developing innovative genomic and bioinformatics technologies for biomedical research and drug discovery. Eclipse Bioinnovations has received multiple federal grant awards from the National Institutes of Health (NIH), particularly from the National Institute of General Medical Sciences (NIGMS) and the National Human Genome Research Institute (NHGRI). These awards support the company's efforts to create advanced platforms and methodologies for analyzing RNA interactions, gene expression, and drug mechanisms of action.

The company's grant-funded projects focus on developing cutting-edge technologies for biomedical research. One such project is the EMOA (Enhanced Multi-Omic Analysis) platform, funded by NIGMS, which aims to provide a multi-omic service for rapid mechanism of action determination in drug screening. This platform combines transcriptomics and translatomics to quickly identify candidate drug compounds and elucidate their precise mechanisms of action, potentially shortening the drug discovery research cycle for biotech and pharmaceutical companies. Another significant project, funded by NHGRI, involves the development of Chimeric-eCLIP technology. This method enables unambiguous identification of microRNA targets in a transcriptome-wide manner, allowing for more precise understanding of microRNA regulation in cellular processes and diseases. The Chimeric-eCLIP project aims to create a robust and versatile kit for widespread use in academic and biotechnology industries, including the development of user-friendly analysis tools and expanded beta testing for commercialization.

Quick answers

Is Eclipse Bioinnovations, Inc. registered in SAM.gov?

Yes. Eclipse Bioinnovations, Inc.'s SAM.gov registration is active through October 14, 2027.

What is Eclipse Bioinnovations, Inc.'s CAGE code?

Eclipse Bioinnovations, Inc.'s CAGE code is 7XLH4, and its Unique Entity ID (UEI) is NKBUXMSL35L8.

What is Eclipse Bioinnovations, Inc.'s most recent federal award?

Eclipse Bioinnovations, Inc.'s most recent federal grant award is Emoa: a multi-omic service for mechanism of action determination in drug screening (R44GM154583), from National Institute of General Medical Sciences (NIH), on July 1, 2024.

On GovTribe

See Eclipse Bioinnovations, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login

Find teaming partners on GovTribe